Why N4VIGATE Healthtech?
At N4VIGATE Healthtech, we focus on clarity, value, and outcomes. We take the time to understand your product vision, commercial ambitions, and current position on the technology-readiness journey, providing objective guidance to help you move forward with confidence and purpose. We do not produce inflated, high-cost proposals, nor do we promote solutions that add little real benefit. Our role is to enable informed decision-making. If N4VIGATE is the right partner, we will support you fully. If not, we will connect you with trusted specialists better aligned to your specific needs. This matters, budgets are finite and often unpredictable, and we are committed to ensuring your investment is directed only toward what is necessary now, and what will deliver the greatest impact as part of a considered go-to-market strategy or improve patient access. Our ambition extends beyond delivering advice. We aim to equip you with the insight, capability, and confidence to execute your plan effectively—and to develop future strategies independently. While we value long-term relationships, our success is measured by how well prepared you are to continue the journey yourselves. As the proverb reminds us: teach a person to fish, and you feed them for a lifetime. We empower teams to go to market with the drive, credibility, and determination that their product deserves. Our approach is culture-led and collaborative, professional, informed, and engaging ensuring that working with N4VIGATE Healthtech is not only effective, but genuinely enjoyable. We also provide additional services which are outlined below.
What We Do
EXPERTS IN NAVIGATING
THE 4TH HURDLE AND BEYOND
Understanding the UK Healthtech landscape and knowing where to begin can be complex. Whether you are developing your UK therapy development patient access plans, your go-to-market strategy, seeking clarity on evidence and access requirements, or supporting global teams to better understand how the NHS operates, N4VIGATE Healthtech provides clear, practical guidance at every stage.
The NHS is many things, but it is not truly national. Its fragmented structure has created a complex ecosystem of public and private routes to market, each offering different approaches, timelines, and costs. For Healthtech companies often operating with significantly leaner budgets than their pharmaceutical counterparts this complexity can be both costly and distracting.
N4VIGATE Healthtech exists to cut through this noise.
Our core expertise is supporting companies overcome the ‘Fourth Hurdle’ helping you demonstrate value beyond regulatory approval by aligning clinical evidence, health economics, reimbursement, and commissioning strategy to the realities of the UK system. We focus on what is genuinely required to achieve adoption and patient access, not on inflated or unnecessary activity.
Our offer is deliberately simple and flexible. We provide independent, proportionate support tailored to your needs and budget whether that is an hour of focused advice to set direction, targeted insight to inform internal decision-making, or more comprehensive strategic support across market access, evidence planning, and policy alignment.
Affordability and transparency sit at the heart of our model. We work with early-stage innovators through to multinational organisations, setting fees that reflect Healthtech realities. We do not up-sell, we do not over-engineer solutions, and we will always advise you on where to stop as well as where to proceed.
Crucially, if N4VIGATE Healthtech is not the right partner for your needs, we will tell you and help connect you to those who are. Where third-party proposals exist, we will help you strip them back to what is truly necessary, ensuring your investment is focused, efficient, and aligned to your strategy whether that is UK go-to-market execution or upstream clinical and economic planning for example.
Our Services
Clear, Independent Support to Help You Confidently Clear the Fourth Hurdle
N4VIGATE Healthtech provides focused, value-led support across four core service pillars. Each is designed to help Healthtech companies navigate the realities of the UK system.
Enquire Now
Please drop us a note.
We will treat all enquiries with the utmost confidentiality, and where appropriate will sign all appropriate Non Disclosure Agreements ahead of formal engagement. If we can assist we will contact you and set up an initial call, to explore your aims further and provide an initial indicative fee proposal. After which, it's over to you to see if you wish to commission our services.
About N4VIGATE
Mark Chapman leads the consulting practice, with over 35 years in the Healthtech Industry.
Mark is the former Board Executive for Healthtech at The National Institute for Health and Care Excellence (NICE). Mark initially trained as a Clinical Physiologist, and worked for 10 years within the UK NHS, Tertiary Cardiac Care, with a specialist interest in complex cardiac devices. Which is where his passion for all things Healthtech and patient access was born.
Moving into Industry in 2001, holding various clinical and commercial and Policy roles. Prior to Joining NICE in 2022, Mark was the Director of Health Economics and Commissioning for UK & Ireland at Medtronic.
In parallel, Mark has held many roles that champion the value of Healthtech for patients, inward investment and research and development. Including committee member on NICE technology appraisal programme, membership of External Advisory Boards for the Engineering and Physical Research Council. (EPSRC), Numerous NHS England Task and Finish groups and Policy advisory work for Office for Life science, Department of Business. He also continues to mentor NHS Innovators via the NHS Mentor programme.
.png)
.png)